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Rheumatic diseases usually promote several systemic
disorders, which can affect blood vessels, mucosa and
serosa of the aerodigestive tract. Scarce laryngeal
involvement has been described in these patients and
this study aims at investigating laryngeal alterations found
in patients with rheumatic diseases. Study design:
transversal cohort. Material and method: A transversal
study was developed with systemic lupus erythematous,
systemic sclerosis and mixed connective tissue disease’s
patients. They were evaluated by means of clinical
examinations and videolaryngoestroboscopy. Results:
Twenty-seven patients were included in the study, 26
succeeded in completing the videolaryngoestroboscopy.
Laryngeal abnormalities were seen in 11 of 12 patients
with lupus, in all 11 patients with sclerodermia and in 3
patients with mixed connective tissue disease. Vocal fold
bamboo node was observed in 5 patients and 92.3% of
all patients presented laryngeal signs of gastroesophageal
reflux disease. Conclusion: We noticed 5 vocal fold
bamboo nodes and gastroesophageal reflux disease in
almost all patients.
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INTRODUCTION
Rheumatic diseases comprise a heterogeneous
group of entities producing connective tissue systemic
disorders. Therefore, they may involve blood vessels and
the aerodigestive serous and mucous structures, particularly
the larynx.
The first laryngeal involvement reported in a systemic
lupus erythematosus patient (SLE) was published in 1959
by Scarpelli et al.1 and, since then, other cases have been
sporadically described. In 1976, Smith et al.2 reported
ulcerations, stenosis and edema of cricoarytenoid units of
two SLE patients. However, Tietel et al.3 published a 97-
case revision on laryngeal involvement in SLE patients, in
which laryngeal edema was found in 28% of patients and
vocal fold paralysis in 11%.
However, laryngeal involvement is not exclusive of
SLE. In a study with 45 patients with fairly severe rheumatoid
arthritis (RA) submitted to indirect laryngoscopy, Lawry et al.4
detected abnormalities in 52% of cases. Diseases such as
scleroderma and Sjögren’s syndrome have also presented
laryngeal involvement. Murano et al.5 described two cases of
what is referred to as “bamboo nodules” and, after specific
exams, those patients were diagnosed for autoimmune disease
(Sjögren’s syndrome and systemic lupus erythematosus).
This study aims at identifying and describing laryngeal
disorders in patients with SLE, scleroderma and mixed
connective tissue disease (MCTD) by means of videostroboscopy
exam of the larynx.
METHOD
This is a transversal study carried out at the
Department of Otorhinolaryngology and Head and Neck
Surgery, Federal University of Sao Paulo / Escola Paulista
de Medicina (UNIFESP/EPM).
The study comprised 12 patients with SLE, 11 with
scleroderma and 3 with mixed connective tissue disease
(MCTD), totalizing 27 patients. All patients were women
within the age range of 19 and 63 years, mean age of 41.2.
Relative to race, 13 were Mulatto, 7 were Black and 6 were
Caucasian.
Patients were included in the study as volunteers,
regardless of presence of laryngeal disorder and duration of
disease. One patient with MCTD and 2 with scleroderma
presented associated Sjögren’s syndrome. All were laboratory
Table 1. Patients with SLE included in the study.
Patient Age · Findings · Antibodies Medication
1 46 · Signs of GERDa · ANAb Prednisone
· Bamboo nodules · Anti-SMd Chloroquine
· Anti-ROe Methotrexate
2 48 · Signs of GERDa  Prednisone
3 48 · Signs of GERDa · ANAb Thalidomide
NSAID
4 45 · Signs of GERDa  Prednisone
Chloroquine
5 47  · ANAb Prednisone
· Anti-RNPc
6 35 · Signs of GERDa · ANAb Prednisone
· Bamboo nodules · Anti-RO/LAe Azathioprine
7 32 · Signs of GERDa · ANAb Prednisone
Chloroquine
Methotrexate
Azathioprine
8 49 · Signs of GERDa · ANAb  
· Anti-RNPc
9 45 · Signs of GERDa  Prednisone
10 56 · Signs of GERDa · ANAb Prednisone
· Anti-SMd Azathioprine
· Anti-RNPc
11 28 · Signs of GERDa · Anti-RNPc Prednisone
· Bamboo nodule · Anti-ROe Chloroquine
12 34 · Signs of GERDa · ANAb Prednisone
· Anti-RNPc Chloroquine
· FRf
a – gastroesophageal reflux disease; b – antinuclear antibody; c –  anti-ribonucleoprotein antibody; d –  anti-antigen SM antibody; e –  anti-
antigen RO or LA antibody; f – rheumatoid factor
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and clinically diagnosed as having rheumatic disease.
Unconfirmed cases of rheumatic diseases were excluded
from the study. Seventeen individuals presented positive
autoantibodies: antinuclear antibody (ANA) found in 16
patients (59.2%) and anti-RNP in 11 patients (40.7%). Fifteen
(57.7%) patients were using prednisone daily at different
doses (Tables 1, 2 and 3).
Patients were submitted to otorhinolaryngological
clinical examination and videolaryngostroboscopy using a
70o rigid telescope introduced into the oral cavity under
topic lidocaine anesthetic spray.
RESULTS
Out of 27 patients formerly included in the study, 26
could undergo videolaryngostroboscopy. One patient with
scleroderma was excluded as she did not succeed in
completing assessment due to intense nausea reflex.
Among 12 patients with SLE, 11 (91.6%) presented
some type of laryngeal disorder (Table 1). The most frequent
alteration found in 11 patients was the presence of edema
and thickening of the interarytenoid region, which has been
described as a sign of gastroesophageal reflux disease
(GERD) (Figure 1). Among these patients, 9 presented
clinical complaints of globus pharyngeus, hoarseness and
dry cough.
Other 3 patients showed yellowish and transversal
deposit lesions of lamina propria, classically referred as
“bamboo nodules” (Figures 2 and 3). A small unilateral vo-
cal sulcus was observed in another patient.
All patients (11) with scleroderma presented laryngeal
alterations (Table 2). Alterations suggestive of GERD were
Table 2. Patients with Scleroderma included in the study.
Patient Age Findings Antibodies Medication
1 44 · Signs of GERDa · ANAb Prednisone
· Anti-RNPd Methotrexate
2 44 · Signs of GERDa   
· Vascular dilations
3 22 · Signs of GERDa · ANAb  
4 63 · Signs of GERDa  Lidocaine IV
5 54 · Signs of GERDa  Prednisone for 10 years
· Laryngeal hypertrophy
6 63 · Signs of GERDa · ANAb  
· Anti-RNPc
· Anti-ROd
7 32 · Signs of GERDa   
8 48 · Signs of GERDa · ANAb  
· Bilateral vascular dilations
9 22 · Signs of GERDa  D- Penicillamine
· Chink + Vocal nodule
10 19 · Signs of GERDa   
11 29 · Signs of GERDa · ANAb  
· Anti-RNPc
· Anti-ROd
· FRe
a – gastroesophageal reflux disease; b – antinuclear antibody; c –  anti-ribonucleoprotein antibody; d –  anti-antigen SM antibody; e –  anti-
antigen RO or LA antibody; f – rheumatoid factor
Table 3. Patients with MCTD included in the study.
Patient Age Findings Antibodies Medications
1 51 · Signs of GERDa  Prednisone
· Chink
2 31 · Signs of GERDa  Chloroquine
· Bamboo nodule
3 36 · Bamboo nodule  Prednisone
Chloroquine
a – gastroesophageal reflux disease
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observed in 11 patients, out of which 6 had clinical
complaints. Two patients presented blood vessels dilation
of vocal folds and 2 had vocal nodules. Signs of laryngeal
hypertrophy were observed in 1 patient (vocal fold
hypertrophy on the prominence of vocal processes).
Out of 3 patients with MCTD, 2 presented “bamboo
nodules” and 2 showed alterations suggestive of GERD
(Table 3). Ten out of 26 patients presented hoarseness and
5 complained of dysphagia.
DISCUSSION
Laryngeal alterations in patients with rheumatic
diseases have been described and may be present in different
diseases and in varied forms. Tietel et al.3, based on a 97-
case revision on SLE with laryngeal involvement, classified
this involvement into 9 categories: mucous inflammation,
infection, vasculitis, paralysis of the vocal fold, cricoarytenoid
arthritis, subglottic stenosis, inflammatory tumor, rheumatoid
nodules and epiglottis. The authors support the fact that
these alterations may be a sign of imminent exacerbation of
disease similarly to other indicators of inflammatory activity.
In our study, out of 12 patients with SLE, 3 exhibited
rheumatoid vocal nodules, which are disorders found in the
list of 9 categories previously described. Although scarce
cases of rheumatoid nodules have been described some
decades ago, Hosako-Naito et al.6 were the most dedicated
group to study these lesions. They described them in patients
with SLE, scleroderma and Hashimoto’s thyroiditis or
“bamboo nodules”.
In a literature revision, Murano et al.5 found 6
described cases of patients with SLE, scleroderma, Sjögren’s
syndrome and MCTD. The authors reported two cases of
suspected autoimmune disease with laryngological findings of
“bamboo nodules” and support nomenclature standardization
for bamboo vocal nodules. Histologically, this lesion shows
areas of linear granulomas with central necrosis surrounded
by macrophages5. However, the laryngoscopic view of lesion
is very similar to an intracordal cyst, even when examined
by an expert professional.
We identified 1 patient with bowed vocal folds and
arytenoid cartilages presenting prominent vocal processes.
Regardless of the typical aspects of presbylarynx in these
findings, we believe that they are caused by rheumatic
disease, considering that the patient was 54 years of age.
Wolman et al.7 performed a post-mortem study in 8 patients
with rheumatoid arthritis and verified that they all had
histological signs of neurogenic muscle atrophy. In addition,
4 patients showed signs of chronic myositis associated with
nerve degeneration.
So far, our study seems to be unique in assessment of
patients with SLE, scleroderma and MCTD, regardless of
presence of laryngeal complaint and of dysphonic process.
Out of 26 patients, alterations were verified in 8 cases, which,
Figure 1. Edema of the retrocricoid region (Arrows).
Figure 2. Bamboo nodule on the middle third of the right vocal fold
(Arrow).
Figure 3. Bamboo nodule on the middle third of the right vocal fold
(Arrow).
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we believe, are laryngeal manifestations of rheumatic
diseases: 5 lesions suggestive of bamboo vocal nodules, 2
vocal folds with blood vessels dilatation, and 1 patient with
hypertrophy of the thyroarytenoid muscle. Even though this
type of disorder has not been described by other authors, it
is interesting to notice it causes great discomfort to the
patient and may contribute to worsen laryngeal affections.
Moreover, we observed signs of GERD in most
patients (92.3%), as well as hoarseness, dry cough and feeling
of a foreign body in the throat in 70.8% of them. Perhaps
esophageal involvement by rheumatic disease, associated
with frequent use of medicines that predispose to GERD, is
responsible for the increased number of patients with GERD
signs.
CONCLUSION
In this study, we could observe laryngeal
lesions related to rheumatic diseases in 8 of 26 patients
assessed. We also identified 5 lesions suggestive of “bamboo
nodules”, which represent the greatest number ever
described. In addition, we observed that all patients showed
laryngeal signs of GERD.
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